Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy
NCT00126815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2016-02-24
Summary
Clinical data are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.
Conditions
Sponsors & Collaborators
-
Cross Cancer Institute
collaborator OTHER -
AHS Cancer Control Alberta
lead OTHER
Principal Investigators
-
Matthew Parliament, MD · AHS Cancer Control Alberta
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-02-29
- Primary Completion
- 2008-03-31
- Completion
- 2008-04-30
Countries
- Canada
Study Locations
More Related Trials
-
Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
NCT00314535 ·Status: COMPLETED
-
Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer
NCT04067570 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
NCT06700057 ·Status: RECRUITING
-
PSMA-Guided Ablation of the Prostate
NCT06003556 ·Status: RECRUITING ·Phase: PHASE2
-
Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
NCT00314522 ·Status: COMPLETED
-
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
NCT00310479 ·Status: COMPLETED ·Phase: NA
-
MRI-guided Ultrahypofractionated SBRT Prostate Program
NCT07132658 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
High-Dose Stereotactic Radiation for Prostate Cancer
NCT01664130 ·Status: COMPLETED ·Phase: NA
-
Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer
NCT01859689 ·Status: WITHDRAWN ·Phase: PHASE2
-
New Markers for Treatment Response to Radiotherapy in Prostate Cancer
NCT06159998 ·Status: WITHDRAWN
-
Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation
NCT00122252 ·Status: TERMINATED
-
The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer
NCT00126802 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
NCT00002511 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
NCT05422105 ·Status: UNKNOWN
-
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT00967889 ·Status: UNKNOWN
-
18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer
NCT04733768 ·Status: COMPLETED ·Phase: PHASE2
-
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate
NCT00585962 ·Status: COMPLETED ·Phase: PHASE2
-
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
NCT04557501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy
NCT00127816 ·Status: COMPLETED ·Phase: NA
-
A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer
NCT00489060 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
NCT00258466 ·Status: WITHDRAWN ·Phase: PHASE3
-
MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy
NCT00775866 ·Status: COMPLETED ·Phase: NA
-
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
NCT05477823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate
NCT01868386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Timing of Post-prostatectomy PSMA Imaging
NCT05008900 ·Status: COMPLETED ·Phase: PHASE2